Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-28 Purchase | 2021-12-29 9:32 pm | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 100,000 | $0.5732 | $57,320 | 325,879 (Direct) | View |
| 2021-12-27 Purchase | 2021-12-28 7:04 pm | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 7,000 | $0.59 | $4,130 | 7,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-06 Tax Withholding | 2022-06-07 4:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $0.2 | 312,973 (Direct) | View |
| 2022-06-06 Tax Withholding | 2022-06-07 4:46 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 89 | $0.2 | 361,761 (Direct) | View |
| 2022-05-31 Tax Withholding | 2022-06-02 4:10 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $0.2066 | 313,198 (Direct) | View |
| 2022-05-31 Tax Withholding | 2022-06-02 4:09 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 61 | $0.2066 | 361,850 (Direct) | View |
| 2022-05-06 Tax Withholding | 2022-05-09 6:33 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 89 | $0.26 | 361,911 (Direct) | View |
| 2022-05-06 Tax Withholding | 2022-05-09 6:32 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $0.26 | 313,305 (Direct) | View |
| 2022-04-30 Tax Withholding | 2022-05-03 4:59 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $0.31 | 313,530 (Direct) | View |
| 2022-04-30 Tax Withholding | 2022-05-03 4:58 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 61 | $0.31 | 362,000 (Direct) | View |
| 2022-04-06 Tax Withholding | 2022-04-08 4:16 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 219 | $0.41 | 313,637 (Direct) | View |
| 2022-04-06 Tax Withholding | 2022-04-08 4:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 89 | $0.41 | 362,061 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 6:27 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 104 | $0.42 | 313,856 (Direct) | View |
| 2022-03-31 Tax Withholding | 2022-04-04 6:26 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 61 | $0.42 | 362,150 (Direct) | View |
| 2022-03-06 Tax Withholding | 2022-03-08 4:14 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 89 | $0.43 | 362,211 (Direct) | View |
| 2022-03-06 Tax Withholding | 2022-03-08 4:12 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 263 | $0.43 | 313,960 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-03-02 7:51 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 125 | $0.45 | 314,223 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-03-02 7:50 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 61 | $0.45 | 362,300 (Direct) | View |
| 2022-02-06 Tax Withholding | 2022-02-08 4:26 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 106 | $0.48 | 362,361 (Direct) | View |
| 2022-02-06 Tax Withholding | 2022-02-08 4:25 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 263 | $0.48 | 314,348 (Direct) | View |
| 2022-01-29 Tax Withholding | 2022-02-01 8:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 10,766 | $0.45 | 314,611 (Direct) | View |
| 2022-01-29 Tax Withholding | 2022-02-01 8:47 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 125 | $0.48 | 314,611 (Direct) | View |
| 2022-01-29 Tax Withholding | 2022-02-01 8:44 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 3,483 | $0.45 | 362,467 (Direct) | View |
| 2022-01-29 Tax Withholding | 2022-02-01 8:44 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 73 | $0.48 | 362,467 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 6:40 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Guico-Pabia Christine J. Chief Medical Officer | 107,200 | $0 | 107,200 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 6:39 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Dolan Daniel CFO | 124,800 | $0 | 124,800 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 6:37 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 359,700 | $0 | 359,700 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 6:35 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 94,800 | $0 | 94,800 (Direct) | View |
| 2022-01-28 Option Award | 2022-02-01 6:34 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 140,100 | $0 | 140,100 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-10 4:19 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 270 | $0.58 | 325,502 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-10 4:18 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 110 | $0.58 | 366,023 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 5:06 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $0.6 | 325,772 (Direct) | View |
| 2021-12-31 Tax Withholding | 2022-01-04 5:05 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $0.6 | 366,133 (Direct) | View |
| 2021-12-06 Tax Withholding | 2021-12-08 5:14 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $0.72 | 225,879 (Direct) | View |
| 2021-12-06 Tax Withholding | 2021-12-08 5:13 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 92 | $0.72 | 366,196 (Direct) | View |
| 2021-11-30 Tax Withholding | 2021-12-02 6:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $0.78 | 226,104 (Direct) | View |
| 2021-11-30 Tax Withholding | 2021-12-02 6:28 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $0.78 | 366,288 (Direct) | View |
| 2021-11-06 Tax Withholding | 2021-11-09 5:38 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 225 | $1.33 | 226,211 (Direct) | View |
| 2021-11-06 Tax Withholding | 2021-11-09 5:36 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 92 | $1.33 | 366,351 (Direct) | View |
| 2021-10-31 Tax Withholding | 2021-11-01 7:51 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R CEO | 107 | $1.15 | 226,436 (Direct) | View |
| 2021-10-31 Tax Withholding | 2021-11-01 7:50 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. COO | 63 | $1.15 | 366,443 (Direct) | View |
| 2021-10-29 Option Award | 2021-11-01 6:10 pm | N/A 2031-10-28 | Nabriva Therapeutics plc | NBRV | Guico-Pabia Christine J. Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |